ARTICLE | Company News
Acambis, Antigenics deal
January 7, 2008 8:00 AM UTC
Acambis exercised an option to receive a non-exclusive license to use Antigenics' QS-21 Stimulon vaccine adjuvant in combination with Acambis' ACAM-FLU-A vaccine. Antigenics is eligible for undisclo...